The peptide chains unfold, aggregate, and form structures that no longer match the active conformation required for biological activity
It operates as a glucagon-like peptide-1 receptor agonist, mimicking the effects of the GLP-1 hormone in your body
The global GLP-1 market was valued at $22 billion in 2025 and is projected to reach $33 billion by 2030
In these cases, many people appreciate having something they can do proactively to reduce their symptoms
Later cases have occurred, so time alone cannot rule out a serious reaction
Interestingly, for those struggling with Type 2 diabetes, insulin resistance and additional criteria could benefit from a GLP-1 receptor agonist and may have an added benefit of improved pelvic floor muscle activation